losartan has been researched along with Embryopathies in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe the reversal of losartan-induced oligohydramnios at 27 weeks of gestation with subsequent development of fetal thrombosis and possible mechanism of action for this extremely rare in utero complication." | 7.73 | In utero losartan withdrawal and subsequent development of fetal inferior vena cava thrombosis. ( Bakkum, JN; Brost, BC; Johansen, KL; Johnston, BW; Watson, WJ, 2006) |
| " The mother suffered from essential hypertension and was treated with Cozaar (losartan 50 mg)." | 3.73 | Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. ( Daïkha-Dahmane, F; Jugie, M; Lenclen, R; Levy-Beff, E, 2006) |
| "We describe the reversal of losartan-induced oligohydramnios at 27 weeks of gestation with subsequent development of fetal thrombosis and possible mechanism of action for this extremely rare in utero complication." | 3.73 | In utero losartan withdrawal and subsequent development of fetal inferior vena cava thrombosis. ( Bakkum, JN; Brost, BC; Johansen, KL; Johnston, BW; Watson, WJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daïkha-Dahmane, F | 1 |
| Levy-Beff, E | 1 |
| Jugie, M | 1 |
| Lenclen, R | 1 |
| Bakkum, JN | 1 |
| Brost, BC | 1 |
| Johansen, KL | 1 |
| Johnston, BW | 1 |
| Watson, WJ | 1 |
2 other studies available for losartan and Embryopathies
| Article | Year |
|---|---|
Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Diseases in Twins; Fema | 2006 |
In utero losartan withdrawal and subsequent development of fetal inferior vena cava thrombosis.
Topics: Angiotensin II Type 1 Receptor Blockers; Contraindications; Diabetes Mellitus, Type 2; Female; Fetal | 2006 |